· 2.2 Flexible Regulatory Approach

We encourage governments to evaluate existing policy tools and use caution before adopting new laws, regulations, or taxes that may inadvertently or unnecessarily impede the responsible development and use of AI. As applications of AI technologies vary widely, overregulating can inadvertently reduce the number of technologies created and offered in the marketplace, particularly by startups and smaller businesses. We encourage policymakers to recognize the importance of sector specific approaches as needed; one regulatory approach will not fit all AI applications. We stand ready to work with policymakers and regulators to address legitimate concerns where they occur.
Principle: AI Policy Principles, Oct 24, 2017

Published by Information Technology Industry Council (ITI)

Related Principles

5. Benefits and Costs

When developing regulatory and non regulatory approaches, agencies will often consider the application and deployment of AI into already regulated industries. Presumably, such significant investments would not occur unless they offered significant economic potential. As in all technological transitions of this nature, the introduction of AI may also create unique challenges. For example, while the broader legal environment already applies to AI applications, the application of existing law to questions of responsibility and liability for decisions made by AI could be unclear in some instances, leading to the need for agencies, consistent with their authorities, to evaluate the benefits, costs, and distributional effects associated with any identified or expected method for accountability. Executive Order 12866 calls on agencies to “select those approaches that maximize net benefits (including potential economic, environmental, public health and safety, and other advantages; distributive impacts; and equity).” Agencies should, when consistent with law, carefully consider the full societal costs, benefits, and distributional effects before considering regulations related to the development and deployment of AI applications. Such consideration will include the potential benefits and costs of employing AI, when compared to the systems AI has been designed to complement or replace, whether implementing AI will change the type of errors created by the system, as well as comparison to the degree of risk tolerated in other existing ones. Agencies should also consider critical dependencies when evaluating AI costs and benefits, as technological factors (such as data quality) and changes in human processes associated with AI implementation may alter the nature and magnitude of the risks and benefits. In cases where a comparison to a current system or process is not available, evaluation of risks and costs of not implementing the system should be evaluated as well.

Published by The White House Office of Science and Technology Policy (OSTP), United States in Principles for the Stewardship of AI Applications, Nov 17, 2020

6. Flexibility

When developing regulatory and non regulatory approaches, agencies should pursue performance based and flexible approaches that can adapt to rapid changes and updates to AI applications. Rigid, design based regulations that attempt to prescribe the technical specifications of AI applications will in most cases be impractical and ineffective, given the anticipated pace with which AI will evolve and the resulting need for agencies to react to new information and evidence. Targeted agency conformity assessment schemes, to protect health and safety, privacy, and other values, will be essential to a successful, and flexible, performance based approach. To advance American innovation, agencies should keep in mind international uses of AI, ensuring that American companies are not disadvantaged by the United States’ regulatory regime.

Published by The White House Office of Science and Technology Policy (OSTP), United States in Principles for the Stewardship of AI Applications, Nov 17, 2020

5 Ensure inclusiveness and equity

Inclusiveness requires that AI used in health care is designed to encourage the widest possible appropriate, equitable use and access, irrespective of age, gender, income, ability or other characteristics. Institutions (e.g. companies, regulatory agencies, health systems) should hire employees from diverse backgrounds, cultures and disciplines to develop, monitor and deploy AI. AI technologies should be designed by and evaluated with the active participation of those who are required to use the system or will be affected by it, including providers and patients, and such participants should be sufficiently diverse. Participation can also be improved by adopting open source software or making source codes publicly available. AI technology – like any other technology – should be shared as widely as possible. AI technologies should be available not only in HIC and for use in contexts and for needs that apply to high income settings but they should also be adaptable to the types of devices, telecommunications infrastructure and data transfer capacity in LMIC. AI developers and vendors should also consider the diversity of languages, ability and forms of communication around the world to avoid barriers to use. Industry and governments should strive to ensure that the “digital divide” within and between countries is not widened and ensure equitable access to novel AI technologies. AI technologies should not be biased. Bias is a threat to inclusiveness and equity because it represents a departure, often arbitrary, from equal treatment. For example, a system designed to diagnose cancerous skin lesions that is trained with data on one skin colour may not generate accurate results for patients with a different skin colour, increasing the risk to their health. Unintended biases that may emerge with AI should be avoided or identified and mitigated. AI developers should be aware of the possible biases in their design, implementation and use and the potential harm that biases can cause to individuals and society. These parties also have a duty to address potential bias and avoid introducing or exacerbating health care disparities, including when testing or deploying new AI technologies in vulnerable populations. AI developers should ensure that AI data, and especially training data, do not include sampling bias and are therefore accurate, complete and diverse. If a particular racial or ethnic minority (or other group) is underrepresented in a dataset, oversampling of that group relative to its population size may be necessary to ensure that an AI technology achieves the same quality of results in that population as in better represented groups. AI technologies should minimize inevitable power disparities between providers and patients or between companies that create and deploy AI technologies and those that use or rely on them. Public sector agencies should have control over the data collectedby private health care providers, and their shared responsibilities should be defined and respected. Everyone – patients, health care providers and health care systems – should be able to benefit from an AI technology and not just the technology providers. AI technologies should be accompanied by means to provide patients with knowledge and skills to better understand their health status and to communicate effectively with health care providers. Future health literacy should include an element of information technology literacy. The effects of use of AI technologies must be monitored and evaluated, including disproportionate effects on specific groups of people when they mirror or exacerbate existing forms of bias and discrimination. Special provision should be made to protect the rights and welfare of vulnerable persons, with mechanisms for redress if such bias and discrimination emerges or is alleged.

Published by World Health Organization (WHO) in Key ethical principles for use of artificial intelligence for health, Jun 28, 2021